{"article_title": "Celgene Bid To Ax FCA Suit Is Premature, US Says", "article_keywords": ["weighed", "false", "whistleblowers", "bid", "premature", "celgene", "fca", "wrong", "drug", "suit", "ax", "view", "york"], "article_url": "http://www.law360.com/articles/547744/celgene-bid-to-ax-fca-suit-is-premature-us-says", "article_text": "Celgene Bid To Ax FCA Suit Is Premature, US Says\n\nLaw360, New York (June 13, 2014, 5:29 PM ET) -- The U.S. government on Thursday weighed in on Celgene Corp.\u2019s bid to nix a whistleblower\u2019s False Claims Act suit in California federal court over alleged off-label drug promotions and kickbacks to doctors, arguing the drug company prematurely moved for dismissal and relied on faulty theories about what constitutes a false claim.\n\n\n\nAlthough it has not intervened in the case, the government argued in a statement of interest that Celgene was wrong to claim the complaint should be axed for failing to allege that providers hadn't \u201ccertified\u201d...\n\nTo view the full article, register now.", "article_metadata": {"description": "The U.S. government on Thursday weighed in on Celgene Corp.\u2019s bid to nix a whistleblower\u2019s False Claims Act suit in California federal court over alleged off-label drug promotions and kickbacks to doctors, arguing the drug company prematurely moved for dismissal and relied on faulty theories about what constitutes a false claim.", "csrf-token": "nvEvmcOifMTkCQmJSi3/7CBwboOS2+FV58OGclhvtq2aFx1nGtwsPkorQDBhm9oe8OH3/cweFLriXfEhsIIS/w==", "og": {"url": "http://www.law360.com/articles/547744/celgene-bid-to-ax-fca-suit-is-premature-us-says", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "Celgene Bid To Ax FCA Suit Is Premature, US Says - Law360"}, "csrf-param": "authenticity_token", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/547744/celgene-bid-to-ax-fca-suit-is-premature-us-says", "viewport": "width=device-width, initial-scale=1.0"}, "_id": "\"57477af36914bd0286fd1298\"", "article_summary": "Celgene Bid To Ax FCA Suit Is Premature, US SaysLaw360, New York (June 13, 2014, 5:29 PM ET) -- The U.S. government on Thursday weighed in on Celgene Corp.\u2019s bid to nix a whistleblower\u2019s False Claims Act suit in California federal court over alleged off-label drug promotions and kickbacks to doctors, arguing the drug company prematurely moved for dismissal and relied on faulty theories about what constitutes a false claim.\nAlthough it has not intervened in the case, the government argued in a statement of interest that Celgene was wrong to claim the complaint should be axed for failing to allege that providers hadn't \u201ccertified\u201d...To view the full article, register now."}